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Abstract Genetic engineering of peanut (Arachis hypo-
gaea L.) using the gene encoding for the nucleocapsid
protein (N gene) of peanut bud necrosis virus (PBNV; genus
Tospovirus, family Bunyaviridae) was used to impart resis-
tance to bud necrosis disease in peanut (PBND), a disease
for which no durable resistance is available in the existing
germplasm. Over 200 transgenic lines of peanut var. JL 24
were developed for which integration and expression of the
transgenes was confirmed by PCR, Southern hybridization,
RT-PCR and western blot analysis. The T1 and T2 genera-
tion transgenic plants were assayed through virus challenge
in the greenhouse by using mechanical sap inoculation at
1:100 and 1:50 dilutions of PBNV, and they showed varying
levels of disease incidence and intensity. Greenhouse and
field evaluation with T2 generation plants indicated some-
what superior performance of the three transgenic events
that showed considerable reduction in disease incidence.
However, only one of these events showed over 75 %
reduction in disease incidence when compared to the
untransformed control, indicating partial and non-durable
resistance to PBND using the viral N-gene.
Introduction
Peanut (Arachis hypogaea L.) is a popular legume crop,
cultivated in over 100 countries across the six continents as
a rich source of edible oil (43–55 %), protein (23–28 %)
and carbohydrates (10–15 %). With an annual world pro-
duction of 37.2 million tons from 23.4 million ha, peanut is
a major oilseed crop that is grown commercially through-
out the tropical, subtropical and warm temperate regions of
the world [20]. It is largely a small-holder crop, grown
under rainfed conditions in semi-arid areas characterized
by unpredictable rainfall, and these areas contribute over
90 % of world peanut production. The low yields of peanut
are primarily due to low inputs, rainfed cultivation of the
crop in marginal lands, non-availability of seed of suitable
high-yielding varieties, and the occurrence of many insect
pests, fungal diseases, and numerous viral diseases at dif-
ferent stages of crop growth.
Peanut bud necrosis virus (PBNV) is a member of the
genus Tospovirus, which includes arthropod-borne, plant-
infecting members of the family Bunyaviridae [26], and it is
transmitted by thrips (Thrips palmi Karmy) in a persistent
manner [38]. PBNV is economically important in South and
Southeast Asian countries, including India, Nepal, Sri
Lanka, Myanmar, Thailand and parts of China [25]. The
disease incidence has been reported to be up to 50 % in
major peanut-growing areas and causes yield losses of over
80 % in the early infected crop [24]. Control of this virus
through cultural practices such as crop rotation, chemical
control of thrips vectors, and removal of alternate weed
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hosts have met with limited success. Hence, the develop-
ment of virus-resistant host plant varieties is the most
promising means of controlling virus diseases in the long
term. At the International Crops Research Institute for the
Semi-Arid Tropics (ICRISAT), although over 8,000 germ-
plasm accessions have been evaluated to identify resistance
to PBNV, durable resistance has not been found, with the
exception of a few lines that were moderately resistant to
the vector [7]. While members of a few wild species of the
genus Arachis have shown good levels of resistance to
PBNV, they are sexually incompatible with the cultivated
varieties and have low yields [1]. Thus, it has become
imperative to look for alternative approaches, and one of the
best possible options is the development of PBNV-resistant
transgenic peanut plants. Genetically engineered resistance
has been actively investigated in recent years as an attrac-
tive option [15]. Expression of virus-derived genes in
transgenic host plants has been shown to result in reduced
susceptibility of the plant to virus infection, and the degree
of protection has ranged from a delay in symptom expres-
sion to absence of symptoms and virus accumulation [10].
The gene encoding the nucleocapsid protein (N gene) of
viruses has been used extensively to impart disease resis-
tance in various crop plants, and the resistance acquired was
correlated either to an RNA-mediated mechanism or high N
protein accumulation [8, 13, 22, 34]. Transgenic peanut
plants have previously been developed for resistance to
various viral diseases by using the viral coat protein and/or
replicase genes [5, 6, 11, 15, 30]. Although the use of the N
gene of PBNV has been demonstrated in Nicotiana tabacum
[37], there are no reports on the development and evaluation
of transgenic peanut plants for conferring resistance to
PBND. Considering the importance and scope of PBND, the
present research work was undertaken to develop and
evaluate transgenic peanut plants using the viral N gene for
pathogen-derived resistance against PBNV.
Materials and methods
Plasmid constructs
The N gene of PBNV (ICRISAT isolate), consisting of 831
nucleotides and encoding a protein of 276 amino acids with a
predicted molar mass of 30.6 kDa, was sequenced and
cloned in pGEM5Z [28]. The plasmid pGEM5Z, carrying
831 bp of the N gene coding sequence was subcloned into
the NcoI and SacI sites of the plasmid pRTL2. The resulting
plasmid, pRTL2:PBNV N-gene (4,731 bp; Online Resource
1), which was maintained in E. coli strain DH5a, has a
double CaMV 35S promoter with a tobacco etch virus (TEV)
leader sequence for enhanced expression of the N gene and
was used for transformation by the biolistic method.
For Agrobacterium tumefaciens—mediated genetic
transformation, the plasmid pRTL2:PBNV N-gene was
digested with SphI, and the end-filled ‘‘N’’ fragment, along
with the promoter (1,853 bp), was subcloned into the end-
filled BamHI site of the binary vector pCAMBIA1301
carrying the reporter gene uidA (GUS) with an intron
driven by the CaMV 35S promoter and nos poly-A ter-
minator sequences along with a CaMV 35S-promoter-dri-
ven hygromycin phosphotransferase (hpt) as the selectable
marker gene. The new plasmid was designated as pCAM-
BIA1301:PBNV N-gene (Online Resource 1) and mobi-
lized into A. tumefaciens strain C 58.
Plant material and transformation
Mature seeds of a popular Spanish-type peanut cultivar, JL
24, were used in all experiments. For biolistic-mediated
gene transfer (BM), a protocol developed earlier [16] was
followed, using the cotyledons and embryonic leaves as
explants, which were bombarded with the plasmid
pRTL2:PBNV N-gene. The PDS-1000 He system (Bio-
Rad) was used for biolistics using gold particle micro-
carriers (1 lm diameter) at a helium gas pressure of 12 kg/
cm2 and partial vacuum of 600 mmHg. A peanut trans-
formation protocol reported previously [30] was followed
for the development of transgenic plants via A. tumefac-
iens—mediated gene transfer (AM). For this, the cotyledon
explants from mature pre-soaked seeds were co-cultivated
with A. tumefaciens strain C 58 harboring the binary
plasmid pCAMBIA 1301:PBNV N-gene.
DNA isolation and PCR analysis
Molecular studies were carried out to confirm the integra-
tion and expression of the introduced genes in the putative
transgenic plants. The genomic DNA was isolated from the
control (untransformed peanut) and putative transgenic
plants using a previously published method [30, 31]. The
presence of the hpt and PBNV N genes in the putative
transformants was confirmed by polymerase chain reaction
(PCR). A 819-bp region of hpt was amplified using 22-mer
oligonucleotide primers (hpt forward primer, 50-CGT TAT
GTT TAT CGG CAC TTT G-30; hpt reverse primer, 50-
GGG GCG TCG GTT TCC ACT ATC G-30). A 585-bp
coding region of the N gene was amplified by using 22-mer
oligonucleotide primers (N forward primer, 50-GCT TGT
AAA AGT GGT AAG TAT G-30; N reverse primer, 50-
ATA ATC ATC CAT TGA GAG ACT G-30). For PCR
amplification, the genomic DNA was denatured at 94 C
for 5 min, followed by denaturation at 94 C for 30 s,
annealing at 55 C for 45 s and extension at 72 C for
1 min for 30 cycles, and then a final elongation step at
72 C for 10 min.
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Analysis of gene expression by RT-PCR
For RT-PCR analysis, total RNA was isolated from
100 mg plant tissue by using TRIzol Reagent (Invitrogen,
USA). Before synthesizing cDNA, the total RNA was
treated with one unit of DNase I and incubated at 37 C to
eliminate the residual DNA. All of the reagents and con-
ditions used were as described for the Protoscript RT-PCR
system for synthesizing the cDNA (New England Biolabs,
USA).
Southern blot analysis
The putative T0 transformants were subjected to Southern
blot hybridization by digesting 15 lg of the genomic DNA
with SphI to release the PBNV N gene, including the
promoter and poly A sequences of pRTL2:PBNV N-gene,
and with XbaI to release the PBNV N gene, including the
promoter of pCAMBIA:PBNV N-gene. To determine the
copy number of the inserts, genomic DNA from the
selected events in the T1 and T2 generations was digested
with restriction enzymes that cut only once within the
T-DNA region: XbaI for pRTL2:PBNV N-gene and SphI
for pCAMBIA:PBNV N-gene. The digested DNA was
separated by electrophoresis on a 0.8 % agarose gel and
transferred to a nylon membrane (Hybond N?, Amersham)
[27]. A PCR-amplified 585-bp fragment of the PBNV N
gene was used as a probe after labeling it using the non-
radioactive AlkPhos direct system (Amersham). Labeling,
hybridization and detection were performed according to
the manufacturer’s instructions.
DAC-ELISA and western blotting
DAC-ELISA was carried out to detect the presence of
PBNV in transgenic plants that were challenged with the
virus in greenhouse experiments, and for the confirmation
of natural infection of plants in field experiment studies.
The antiserum that was used for western blotting was also
used for DAC-ELISA. ELISA tests were carried out once
for the infected leaves (after 1 week) and twice for the
systemic leaves at 20 and 30 days after inoculation. The
standard protocol for direct antigen-coated ELISA was
followed [23]. Leaf extracts (100 mg in 1 ml of 50 mM
sodium carbonate buffer, pH 9.6) were coated onto the
wells of an ELISA plate (MaxiSorb, NUNC). PBNV anti-
bodies at a dilution of 1:10,000 (v/v) were added into the
wells of the ELISA plate and incubated at 37 C for 1 h,
followed by incubation with alkaline-phosphatase-con-
jugated goat anti-rabbit IgG antibody for 1 h at 37 C.
p-nitrophenyl phosphate (0.05 mg/mL) was used as a
substrate before incubating the plates at room temperature.
The reaction was measured in an ELISA plate reader fitted
with a 405-nm filter (SpectraMax Plus microplate reader,
Molecular Devices, USA) after addition of the substrate
and incubation of the plates for 30, 60 or 120 min.
Western blotting was carried out to analyze the
expression level of the N protein, using the protein isolated
with TRIzol Reagent (Invitrogen, USA) and PBNV NP
antibodies. The total protein was isolated from 500 mg leaf
tissue under liquid nitrogen, extracted in 0.5 ml of 0.03 M
potassium phosphate buffer (pH 7.5) and 10 mM
2-mercaptoethanol, and centrifuged at 13,000 rpm for
5 min. The protein content in the extract was quantified by
the Bradford method (Bradford 1976). Fifty lg of the
protein was combined with equal volumes of Laemmli
buffer, heat-denatured by boiling in a water bath for 3 min,
and separated by 12 % sodium dodecyl sulfate (SDS)
polyacrylamide gel electrophoresis (PAGE) followed by
immunoblotting onto a nitrocellulose membrane using a
semi-dry transfer apparatus [27]. The PBNV NP was
detected using a rabbit anti-PBNV NP polyclonal serum as
a primary antibody (cross-absorbed polyclonal antibody)
and goat anti-rabbit IgG coupled to alkaline phosphatase
(Sigma catalog no. A3687) as a secondary antibody.
Positive reactions were detected using BCIP-NBT substrate
(Sigma catalog no. B1911).
Virus challenge studies
PBNV (ICRISAT isolate) maintained on cowpea plants
was used for preparation of the inoculum. Thirty-five T1
transgenic events (20 events produced using BM and 15
produced using AM) were selected for bioassays under P2-
level greenhouse conditions. Nine seeds from each trans-
genic event, including a susceptible control, JL 24, were
sown and replicated three times. All of the test plants were
examined for integration of the transgene by PCR and RT-
PCR. From each event, six seedlings were selected for
inoculation, and the remaining three were kept as uninoc-
ulated controls. Virus inoculum was freshly prepared from
the infected leaves of cowpea ground in 50 lM potassium
phosphate buffer at 1:100 dilution (w/v) under ice-cold
conditions. The virus inoculum was rubbed onto all of the
opened leaves of 8- to 10-day-old test seedlings and rinsed
with deionised water after 2 h. All of the pots were
maintained at 25 C and 75 % RH in a contained green-
house for uniform infection. Disease development on the
inoculated plants was monitored by DAC-ELISA tests and
visual observations. The observations that were recorded
included the number and percent of plants infected in each
transgenic event, the number of positive plants showing
infection, the number of negative plants showing infection,
and percentage increase/decrease of disease over the con-
trol plants. The plants that did not show infection were
advanced to further generations for subsequent evaluations.
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In another set of experiments, 24 T2-generation transgenic
lines involving 13 events from AM and 11 events from
BM, including four lines derived from cotyledonory
explants and seven derived from embryonic leaf transfor-
mation, were used for virus challenge studies with the sap
extracts (1:50 w/v).
Contained field evaluation
A contained field trial was conducted following approval
from the regulatory authorities in India. The field trial was
carried out in an isolated area on the farms of ICRISAT,
Patancheru, India, during August-December in 2005.
Twenty-four T2 transgenic lines that had previously been
screened in greenhouse virus-challenge tests were selected
and evaluated. The field trial was done using plants from
24 test events and four controls of the non-transgenic
peanut variety JL 24 in three replications. Each test event
and control had eight seeds per replication and was planted
in two rows at a distance of 30 9 50 cm in a plot size of
1 9 1.2 m. Each plot was separated by an 80-cm space,
and each replication was separated from the others by 1.0-
m alley paths. Two rows of non-transgenic peanut and
pearl millet were grown surrounding the experimental
areas as trap crops. Observations on the number of disease-
free and diseased plants were recorded periodically.
Among the infected plants, the severity of the disease, viz.,
mosaic leaf symptoms (MLS), apical bud necrosis (ABN),
severe necrosis (SN), and mortality (M) were recorded
separately for each event and compared with controls. All
of the plants, irrespective of symptoms, were tested by
ELISA for the presence or absence of PBNV. The obser-
vations on disease incidence (DI) were recorded, and
analysis of data for the actual number of positive plants in
each event was carried out.
Statistical analysis
Transformation experiments were conducted using a ran-
domized design and repeated at least three times. Data
from greenhouse and field studies were analyzed by anal-
ysis of variance (ANOVA) to detect significant differences
between the means.
Results
Genetic transformation studies
A total of 900 cotyledon and embryonic leaflet explants of
peanut were used in three batches through Agrobacterium-
and biolistic-mediated genetic transformation with the
PBNV N gene resulting in a total of 375 putative
transformants (Online Resource 2). The shoot buds induced
in Agrobacterium-mediated gene transfer were initially
selected with 2 lg ml-1 hygromycin (2 lg ml-1) followed
by selection on 5 lg ml-1 hygromycin during the sub-
sequent subcultures of 2–3 weeks until rooting on the
selection-free medium.
For the biolistic-mediated gene transfer, the embryonic
leaflet explants cultured on the shoot-induction medium
(SIM) turned green and underwent considerable enlarge-
ment within 2–3 days of culture, followed by the induction
of multiple adventitious shoot buds from the petiolar cut
ends in over 80 % the explants within 2–3 weeks. After
two subcultures on SIM, explants with the differentiated
shoot buds were transferred to shoot elongation medium
(SEM) for three subcultures of 4 weeks each. The elon-
gated shoots were rescued at the end of each subculture and
transferred to root-induction medium (RIM), where they
developed adventitious roots in over 77 % of the elongated
shoots within 2 weeks. Since there was no antibiotic mar-
ker for selection of the transformed plants, PCR was used
to select the transformed plants at the rooting and/or
greenhouse stage (T0 generation). The confirmed PCR-
positive transgenic events were advanced to further
generations.
Molecular analysis
Putative transformants were screened by PCR and RT-PCR
analysis to confirm the presence and expression of trans-
genes (Online Resource 3). Oligonucleotide primers spe-
cific for the N (585 bp) and hpt (819 bp) genes were
amplified to produce a gene fragment of the expected size
in 72 and 83 %, respectively, of the T0 putative transfor-
mants transformed with Agrobacterium tumefaciens. In the
other set of transformants that were produced using BM,
the transgene amplification indicated a transformation
frequency of 39.4 and 44 % in cotyledonary and embryonic
leaf explants, respectively. Furthermore, the cDNA isolated
from the putative transgenic plants showed amplification of
the 585-bp fragment of the N gene in 62 % of AM trans-
formants. However, a relatively lower number (26 %) of
the transgenic plants derived from BM expressed the
transgene, as shown by RT-PCR.
Southern blot analysis was carried out with the selected
transformants in the T0 and T1 generations to ascertain the
integration and copy number of the transgenes (Fig. 1a, b).
A total of 15 of the 24 tested transgenic plants produced
using Agrobacterium-mediated transformation showed
hybridization signals, while seven of the 21 plants tested,
and 12 of 26 plants tested that were obtained from the BM
leaflets and cotyledonary explants, respectively, were
positive for the transgene. Moreover, 13 out of the 15
Agrobacterium-mediated transformed plants showed the
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presence of a single site of integration. Analysis of the
putative transgenic plants obtained through BM of
embryonic leaflets and cotyledonary explants with the
plasmid pRTL2:PBNV N gene revealed single-copy inte-
gration in five and four plants, respectively.
DAC-ELISA was used with polyclonal antiserum
against PBNV (ICRISAT isolate) to detect virus infection
in the transgenic plants in the T1 generation. All of the 35
tested transgenic events showed varied levels of reaction.
The OD readings ranged from 0.125 to 1.472, compared to
a reading of 2.418 for a PBNV-infected peanut plant that
was used as a positive control. PBNV N gene expression in
the leaf samples was detected in the transformed plants, but
not in the untransformed controls, when tested by immu-
noblot analysis. The PBNV antibodies detected 33-kDa
products that had the same electrophoretic mobility as the
PBNV nucleoprotein obtained from infected leaves of
wild-type plants (Fig. 1c).
Segregation analysis
PCR analysis of the transgenes was carried out to charac-
terize the inheritance of the transgene in the T1 and T2
generations to study the stability of the introduced trans-
gene (Online Resource 4). The results indicated that[95 %
of the plants in the T1 and T2 generations showed a Men-
delian segregation ratio of 3:1.
Greenhouse evaluation
Virus challenge of the transgenic plants using sap extracts
prepared from PBNV-infected cowpea plants at a 1:100
dilution was carried out in a contained greenhouse for 35
independent transgenic events in the T1 generation (20
events with BM) and 15 events derived from AM along
with untransformed parent JL 24 (Table 1). The results
indicated that 16 out of 35 lines (45.7 %) did not acquire
the virus, whereas 19 (54.3 %) that acquired the virus
showed varied levels of disease intensity. Among the 19
transgenic plant lines that were infected, the disease inci-
dence (DI) in seven ranged from 1 to 25 %, in five, it was
26–50 %, in six, it was 51–75 %, and in one, it was higher
than 75 %. Similarly, variations in infectivity were
observed amongst the transgenic events, where six lines
(30 %) remained infection-free and 14 produced using BM
(70 %) acquired the virus, while ten (66.6 %) produced
using AM were free, and five (33.3 %) acquired the virus.
The disease incidence (DI) was recorded for each event,
and the percent increase or decrease and plant mortality
over control was calculated.
Based on preliminary screening, 24 transgenic events
(13 produced using AM and 11 produced using BM) were
selected for the advancement of generation (T2) so as to
repeat the virus challenge at higher virus concentration
[1:50] in the greenhouse (Fig. 2). At this concentration,
most of the plants were infected to some extent and showed
varying degrees of disease progress and survival (Online
Resource 5). Although 100 % of the untransformed control
plants died by 3 weeks after inoculation, the transgenic
plants did not show any signs of infection until after
2 weeks. The mortality in the transgenic lines due to PBNV
infection was recorded as 58.1, 74.8, 84.8, 97 and 100 % in
the third, fifth, seventh, ninth, tenth week as well as after
ten weeks post-inoculation, respectively, indicating that
although two of the transgenic plant lines survived up to
10 weeks post-inoculation, these eventually succumbed to
the disease.
Fig. 1 Molecular characterization of selected T1 generation trans-
genic peanut plants using southern and western blot analysis.
a Southern blot of genomic DNA from eight transgenic plant lines
that were transformed using biolistics. The DNA was digested with
XbaI, which cuts once within the T-DNA region. Lanes 1–8, events
B-1, B-4, B-6, B-7, B-10, B-12, B-20, and B-20. Lane C is
untransformed control, lane P is the DNA of plasmid
pRTL2:PBNVng digested with XbaI; b Southern blot of genomic
DNA from nine transgenic plant lines that were transformed with
Agrobacterium tumefaciens and digested with SphI, which cuts once
within the T-DNA region. Lanes 1–9, events A-A, A-C, A-K, A-J,
A-D, A-E, A-F, A-G, and A-H. Lane C is untransformed control.
Lane P is the plasmid DNA of pCAMBIA1301:PBNVng digested
with SphI; c Western blot analysis of seven transgenic events. Lane IP
is a PBNV-infected sample of peanut, lane 1 is a protein marker,
lanes 2–8 are events B-1, A-K, B-11, B-4, A-A, A-C, and A-J. Lane C
is the untransformed control
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Evaluation under field conditions
Twenty-four transgenic lines in the T2 generation (13 AM
and 11 BM) that showed integration of the PBNV N gene
and remained either infection-free or had less viral infec-
tion following virus challenge tests I and II were selected
for evaluation under natural field conditions (Fig. 3). The
initial mosaic symptoms were observed in seedlings from 2
to 3 weeks after germination, and the disease incidence
(DI) was monitored and recorded fortnightly until the
plants reached maturity. The disease incidence (DI) in the
untransformed control plants was 85.4 %, with severity of
16.6, 35.4, 24 and 9.4 % of MLS, ABN, SN and mortality,
respectively. Among the test events, the disease incidence
and intensity were variable, where the disease incidence
(DI) of the test events was measured on a 0–4 scale, viz., 0
(Nil), 1 (1–25 %), 2 (26–50 %), 3 (51–85 %) and 4
([85 %, maximum disease incidence as untransformed
control).
The disease incidence (DI) analyzed on the basis of
transformation method indicated that in the transgenic
events obtained through BM, one had a lower disease
incidence (1–25 %), two had a 26–50 % disease incidence,
seven were in a range of 51–85 % disease incidence and
one was above 85 %. However, none of the events from
AM were in the range of 1–25 % disease incidence, while
three had 26–50 % disease incidence, six had 51–85 %
disease incidence, and four had a disease incidence of
[85 %. Based on these results, nine (from both BM an
AM) with a lower disease incidence (35–80 %) over the
untransformed controls were identified as better performers
under field evaluation (Table 2; Fig. 3). Overall, in the
field evaluation studies, only one transgenic plant line
showed a modest reduction in disease incidence (17.7 %)
when compared to the other five that showed 42–51 %
reduction in disease incidence and to untransformed con-
trols. Also, based on the percent disease resistance (DR),
calculated in terms of disease incidence and healthy plants
over the control, the progeny of event GNPBNV-B-1 was
ranked as best (67 %), followed by GNPBNV-A-K
(43.7 %) and GNPBNV B-11 (41.7 %) (Fig. 4).
Discussion
Introduction of the viral N gene by genetic transformation is
a rapid and effective means to generate novel resistance
against viral diseases in crop plants. In the present study,
transgenic peanut plants were developed for resistance
against PBND by introducing the PBNV N gene using two
methods of gene transfer. The resulting transgenic plants
were analyzed molecularly as well as in virus bioassays
under greenhouse and field conditions. A total of 15 trans-
genic plants were generated using Agrobacterium-mediated
transformation [30, 31], resulting in 43 % regeneration
frequency and a transformation frequency of over 72 %.
The transformation procedure based on biolistics used for
direct gene transfer resulted in overall shoot regeneration
and transformation frequencies of 47 and 39.4 %, respec-
tively, with cotyledonary explants, and 34 and 44 %,
Table 1 Evaluation of 10-day-old transgenic peanut plants (T1
generation) under contained greenhouse conditions following chal-
lenge with PBNV at a 1:100 dilution
Sample no. Event no. Number of PCR
positive plants
Disease
incidence (%)
Inoculated Infected
1 B-1 9 0 0
2 B-2 8 5 62.5
3 B-3 8 1 12.5
4 B-4 4 1 25
5 B-6 7 0 0
6 B-7 5 1 20
7 B-8 5 0 0
8 B-9 4 3 75
9 B-10 2 0 0
10 B-11 6 2 33.3
11 B-12 2 0 0
12 B-13 4 2 50
13 B-14 2 0 0
14 B-15 3 2 66.6
15 B-19 7 5 71
16 B-20 6 1 16.7
17 B-21 6 2 33.3
18 B-22 5 4 80
19 B-26 3 2 66.6
20 B-30 5 3 60
21 A–A 4 0 0
22 A-B 5 0 0
23 A-C 8 0 0
24 A-D 6 0 0
25 A-E 2 1 50
26 A-F 5 2 40
27 A-G 6 0 0
28 A-H 5 1 20
29 A-I 6 1 16.7
30 A-J 5 1 20
31 A-K 3 0 0
32 A-L 2 0 0
33 A-M 3 0 0
34 A-N 4 0 0
35 A-P 4 0 0
Control JL 24 6 4 66.6
Disease incidence was measured for 2–7 weeks post-inoculation
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respectively, with embryonic leaflets. Also, the transfor-
mation efficiency obtained in this study by the biolistic
method is the highest reported so far when compared to
previous reports [2–4, 21, 29, 36], thereby indicating that
embryonic leaflets and half cotyledons of peanut can also be
used as suitable explants for transformation of peanut by the
biolistic method.
Using both direct and indirect methods for peanut
transformation, out of the 35 putative transgenic events
tested in the T0 generation, 22 had single-copy inserts. The
number of transgenic events carrying the single copy
inserts was lower in the ones produced by the biolistic
method when compared to Agrobacterium-mediated
transformation. High copy number has been known to be a
Fig. 2 Evaluation of transgenic peanut plants in a contained
greenhouse by challenge with the PBNV inoculum at 1:50 dilution.
a Indicator cowpea plants showing severe necrotic symptoms within
1 week after inoculation, b transgenic plants showing varied levels of
disease incidence, c seedlings of untransformed control plants
showing mortality at 2 weeks after inoculation (arrow), d inoculated
seedlings of transgenic plant B-9 showing mortality (arrow) at
5 weeks after inoculation, e, f transgenic plnats A-A and B-1,
showing survival at 9 weeks after inoculation
Pathogen-derived resistance in transgenic peanut 139
123
Fig. 3 Evaluation of resistance of selected transgenic peanut plants
to natural infection by PBNV in a contained field. a, b General view
of the field experiment with pearl millet as a border crop and
untransformed peanut plants raised in two rows outside the plot. c A
transgenic plant line (B-1) showing healthy and disease-free plants. d,
e Various disease symptoms of PBND observed on test plants.
d mosaic, e apical bud necrosis, f severe necrosis
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common feature associated with the biolistic method of
transformation [12]. Nevertheless, upon advancement of
generations, all the 16 transgenic plants (100 %) in the T1
generation and 23 out of 24 (96 %) in T2 generation fol-
lowed the Mendelian segregation ratio of 3:1. Based on
these results, it is evident that the transgene was trans-
mitted to and expressed in the successive progeny.
The virus challenge experiments with T1 generation
transgenic plants of peanut revealed that 16 of the 35 tested
transgenic plant lines (45.7 %) did not acquire the virus
under the conditions of the greenhouse assays. However, in
the T2 generation, only three transgenic events, viz.,
GNPBNV B1-2, GNPBNV AK-3 and GNPBNV B11-2,
showed a 40 to 67 % decrease in disease incidence and
were considered to be superior under greenhouse condi-
tions. These results indicated that 19 out of 35 lines could
be infected at a virus dilution of 1:100, whereas at a 1:50
dilution, all of the transgenic plants tested were infected.
However, the disease severity varied among the transgenic
events at different periods post-inoculation. Most of the
plants survived up to 3–9 weeks post-inoculation (WPI),
but only two survived up to ten WPI when compared to the
untransformed controls, which survived only for two WPI.
Based on these preliminary data, the delay in expression of
symptoms and mortality was attributed to the resistance
gained due to the presence of the transgene in these plants.
Nevertheless, for subsequent contained field evalua-
tions, a high level of natural infection of PBNV prevailed
during the test period, which was an added advantage for
screening for resistance. Under field conditions, while
three transgenic lines (GNPBNV-B-1-2-1, GNPBNV-A-
K-3-4 and GNPBNV B-11-2-3) showed a considerable
reduction in disease incidence, only one (GNPBNV-B-1-
2-1) showed less than 20 % disease incidence and
emerged as somewhat resistant to PBND. These variations
among the transgenic events under field conditions were
comparable to the results of virus challenge test at 1:50
dilution carried out under greenhouse conditions, thereby
indicating that the highly efficient mechanical inoculation
is likely to introduce a greater amount of virus inoculum
when compared to thrips-mediated natural infection [39].
Nevertheless, the transgenic plants in our study had fewer
necrotic spots than did controls grown under identical
conditions.
Table 2 Evaluation of
transgenic plants of T2
generation peanut by PBNV
challenge under contained field
conditions (n = 8)
* MLS mild leaf symptoms,
ABN apical bud necrosis, SN
severe necrosis, M mortality
Event DI Disease severity (%)* Relative DI reduction
over control (%)
MLS ABN SN M
PB (B)-1 17.7 5.9 5.9 5.9 0 79.3
PB (B)-3 53.3 13.3 26.7 13.3 0 37.6
PB (B)-4 46.2 15.4 7.7 23.1 0 45.9
PB (B)-6 54.1 17.7 17.7 17.7 0 37.8
PB (B)-7 56.2 12.5 25 12.5 6.2 34.2
PB (B)-10 75.0 6.3 37.5 31.2 0 11.9
PB (B)-11 43.70 18.7 25 0 0 48.8
PB (B)-12 86.70 13.3 33.3 40.1 0 –
PB (B)-14 69.60 11.8 35.3 23.5 0 17.1
PB (B)-20 81.80 22.2 44.5 11.1 0 8.9
PB (B)-21 72.20 11.1 33.3 22.2 5.6 15.4
PB (A)-A 46.20 15.4 23.1 7.7 0 15.5
PB (A)-B 75 16.7 25 33.3 0 45.9
PB (A)-C 50 14.3 28.6 7.1 0 41.5
PB (A)-D 100 29.4 35.3 35.3 0 –
PB (A)-E 83.70 16.7 27.8 38.8 0 2.5
PB (A)-F 82.30 23.5 29.4 23.5 5.9 3.6
PB (A)-G 88.90 11.1 27.8 44.4 5.6 –
PB (A)-H 100 13.3 33.3 53.4 0 –
PB (A)-I 87.80 22.2 44.5 11.1 0 8.9
PB (A)-J 52.90 11.8 23.5 17.6 0 38.0
PB (A)-K 41.70 16.7 25 0 0 51.2
PB (A)-L 88.90 16.8 33.3 38.8 0 –
PB (A)-N 70.50 17.6 35.3 17.6 0 17.4
Control 85.40 16.6 35.4 24 9.4 –
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During the course of the investigation presented here,
although most of the transgenic plants were confirmed to
express the transgene, only three lines (GNPBNV-B-1-2-1,
GNPBNV-A-K-3-4 and GNPBNV B-11-2-3) in the T2
generation eventually exhibited a considerable level of
resistance, while others showed susceptibility or low levels
of resistance under greenhouse and field conditions. This
indicates the possible occurrence of transgene silencing in
these transgenic plants. Occurrence of transgene silencing
has also been reported previously in transgenic sorghum
plants obtained by the biolistic method of transformation
[9]. These results are also in agreement with previous
findings in which low to medium expression levels of the
viral transgenes in peanut have been observed [15, 18, 39].
Also, progeny of the transgenic peanut plants developed for
resistance to alfalfa mosic virus (AMV) accumulated
detectable amounts of the viral coat protein but remained
susceptible to the virus under greenhouse conditions [35].
This unexpected behavior and considerable variation in the
expression of transgenes could not be attributed only to the
copy number but were also influenced by other factors such
as the strength of the promoter, epigenetic factors, posi-
tional effect, inherent host genome, pre- and post-tran-
scriptional, and translational processes [19, 32].
This is the first report on generating transgenic peanut
plants exhibiting a modest tolerance to PBND both under
greenhouse and field conditions, where one transgenic
event showed partial resistance (\20 % disease incidence,
DI) under natural infection under field conditions. This
apparent lack of resistance to PBND in the transgenic
plants could be due to the presence of RNA silencing
suppressor gene, (NSs) in the PBNV genome that render
the PBNV N gene ineffective [14, 17, 33]. However,
considering the unexpectedly low frequency of virus-
resistant plants throughout the challenge experiments, it is
concluded that an alternate strategy based on RNA-inter-
ference-mediated gene silencing (antisense and hairpin
RNA) could be a potential tool for achieving more efficient
protection against PBNV.
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